2. Ha SM, Ko DY, Jeon SY, Kim KH, Song KH. A clinical and statistical study of cutaneous malignant tumors in Busan city and the eastern Gyeongnam province over 15 years (1996~2010). Korean J Dermatol 2013;51:167-172.
3. Gordon R. Skin cancer: an overview of epidemiology and risk factors. Semin Oncol Nurs 2013;29:160-169.
4. Goldsmith LA, Fitzpatrick TB. Fitzpatrick's dermatology in general medicine. 8th ed. New York: McGraw-Hill Medical; 2012.
5. Gandhi SA, Kampp J. Skin cancer epidemiology, detection, and management. Med Clin North Am 2015;99:1323-1335.
7. Hussein MR. Ultraviolet radiation and skin cancer: molecular mechanisms. J Cutan Pathol 2005;32:191-205.
8. Kozma B, Eide MJ. Photocarcinogenesis: an epidemiologic perspective on ultraviolet light and skin cancer. Dermatol Clin 2014;32:301-313.
9. D'rrico M, Calcagnile A, Canzona F, Didona B, Posteraro P, Cavalieri R, Corona R, Vorechovsky I, Nardo T, Stefanini M, Dogliotti E. UV mutation signature in tumor suppressor genes involved in skin carcinogenesis in xeroderma pigmentosum patients. Oncogene 2000;19:463-467.
10. Lesiak A, Sysa-Jedrzejowska A, Narbutt J. The role of sonic hedgehog pathway in skin carcinogenesis. Pol Merkur Lekarski 2010;29:141-143.
11. Korean Dermatological Association. Textbook of dermatology. 6th ed. Seoul: Medbook; 2014.
12. Goldenberg G, Perl M. Actinic keratosis: update on field therapy. J Clin Aesthet Dermatol 2014;7:28-31.
13. Green A, Battistutta D. Incidence and determinants of skin cancer in a high-risk Australian population. Int J Cancer 1990;46:356-361.
14. Feldman SR, Fleischer AB Jr. Progression of actinic keratosis to squamous cell carcinoma revisited: clinical and treatment implications. Cutis 2011;87:201-207.
16. Stockfleth E, Ferrandiz C, Grob JJ, Leigh I, Pehamberger H, Kerl H;. Development of a treatment algorithm for actinic keratoses: a European Consensus. Eur J Dermatol 2008;18:651-659.
17. Wong SS, Tan KC, Goh CL. Cutaneous manifestations of chronic arsenicism: review of seventeen cases. J Am Acad Dermatol 1998;38:179-185.
18. Kim BJ, Kim SY, Kim GM. A case of multiple SCCs in situ and BCC induced probably by chronic exposure to arsenic-containing pills (Hwan-Yak). Korean J Dermatol 2009;47:1071-1073.
20. Yun SJ, Kwon OS, Han JH, Kweon SS, Lee MW, Lee DY, Kim MB, Kim YC, Yoon TY, Chung KY, Kim IH, Kim KH, Suh KS, Lee SJ, Seo YJ, Kim KH, Park HJ, Roh MR, Ahn KJ, Yoon TJ, Kim MH, Li KS, Park JS, Shin BS, Ko JY, Ahn HH, Kim HJ, Park SD, Jang SJ, Won YH. Clinical characteristics and risk of melanoma development from giant congenital melanocytic naevi in Korea: a nationwide retrospective study. Br J Dermatol 2012;166:115-123.
21. McArthur GA, Chapman PB, Robert C, Larkin J, Haanen JB, Dummer R, Ribas A, Hogg D, Hamid O, Ascierto PA, Garbe C, Testori A, Maio M, Lorigan P, Lebbe C, Jouary T, Schadendorf D, O'Day SJ, Kirkwood JM, Eggermont AM, Dreno B, Sosman JA, Flaherty KT, Yin M, Caro I, Cheng S, Trunzer K, Hauschild A. Safety and efficacy of vemurafenib in BRAF(V600E) and BRAF(V600K) mutation-positive melanoma (BRIM-3): extended follow-up of a phase 3, randomised, open-label study. Lancet Oncol 2014;15:323-332.
23. Jung HJ, Kweon SS, Lee JB, Lee SC, Yun SJ. A clinicopathologic analysis of 177 acral melanomas in Koreans: relevance of spreading pattern and physical stress. JAMA Dermatol 2013;149:1281-1288.
25. Neale R, Williams G, Green A. Application patterns among participants randomized to daily sunscreen use in a skin cancer prevention trial. Arch Dermatol 2002;138:1319-1325.
26. Autier P, Boniol M, Severi G, Dore JF. European Organizatin for Research and Treatment of Cancer Melanoma Co-operative Group. Quantity of sunscreen used by European students. Br J Dermatol 2001;144:288-291.
27. Kim SM, Oh BH, Lee YW, Choe YB, Ahn KJ. The relation between the amount of sunscreen applied and the sun protection factor in Asian skin. J Am Acad Dermatol 2010;62:218-222.
29. Mason RS, Reichrath J. Sunlight vitamin D and skin cancer. Anticancer Agents Med Chem 2013;13:83-97.
30. Terushkin V, Bender A, Psaty EL, Engelsen O, Wang SQ, Halpern AC. Estimated equivalency of vitamin D production from natural sun exposure versus oral vitamin D supplementation across seasons at two US latitudes. J Am Acad Dermatol 2010;62:929.e1-929.e9.
31. Bolland MJ, Grey A, Gamble GD, Reid IR. The effect of vitamin D supplementation on skeletal, vascular, or cancer outcomes: a trial sequential meta-analysis. Lancet Diabetes Endocrinol 2014;2:307-320.
32. Autier P, Boniol M, Pizot C, Mullie P. Vitamin D status and ill health: a systematic review. Lancet Diabetes Endocrinol 2014;2:76-89.
33. Vieth R. Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. Am J Clin Nutr 1999;69:842-856.
35. Holick MF. Sunlight “D”ilemma: risk of skin cancer or bone disease and muscle weakness. Lancet 2001;357:4-6.
36. Reichrath J, Nürnberg B. Cutaneous vitamin D synthesis versus skin cancer development: the Janus faces of solar UV-radiation. Dermatoendocrinol 2009;1:253-261.
37. Rosso S, Zanetti R, Martinez C, Tormo MJ, Schraub S, Sancho-Garnier H, Franceschi S, Gafa L, Perea E, Navarro C, Laurent R, Schrameck C, Talamini R, Tumino R, Wechsler J. The multicentre south European study ‘Helios’. II: different sun exposure patterns in the aetiology of basal cell and squamous cell carcinomas of the skin. Br J Cancer 1996;73:1447-1454.